Is it growing?
Is TEVA growing?
Teva Pharmaceutical Industries Limited has grown revenue −1.8% a year over three years and −2.8% a year over five.
−1.8%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · shrinking · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- −2.8%
Revenue growth, 5-year rate · −1.8% over three · growth has picked up over the last three years
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $15.9B
- Revenue FY2022
- $14.9B
- Revenue FY2023
- $15.8B
- Revenue FY2024
- $16.5B
- Revenue FY2025
- $17.3B
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #15 of 28 by Smart Score